Mary Jo Fidler to Gene Expression Regulation, Neoplastic
This is a "connection" page, showing publications Mary Jo Fidler has written about Gene Expression Regulation, Neoplastic.
Connection Strength
0.124
-
Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer. Lung Cancer. 2011 Feb; 71(2):186-90.
Score: 0.091
-
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. Lancet. 2016 Apr 09; 387(10027):1540-1550.
Score: 0.033